Dabur India Non-Executive Chairman Mr. Amit Burman Hospitalised
Dabur India Ltd today announced that Non-Executive Chairman Mr. Amit Burman has been hospitalised in London and is undergoing treatment for a case of Aneurysm.
Mr. Burman is recuperating after undergoing surgery. The surgery was successful, and his health is improving. Doctors are constantly monitoring his condition and have advised him to take rest.
TCS Recognized as a Leader in IDC MarketScape for Asia-Pacific Cloud Security Services
A leading global IT services, consulting and business solutions organization, has been positioned as a Leader in the IDC MarketScape for Asia/Pacific Cloud Security Services
According to the report, “TCS has one of the most comprehensive cloud security portfolios in the market, addressing the entire lifecycle stages of cloud adoption.” It goes on to say, “Having worked with clients from various industries and sectors, TCS is able to bring what it considers ‘contextual knowledge’ to develop product and service packages that fit clients' needs in the region.”
“The speed of evolution of cyber threats in the cloud ecosystem is increasingly seen as the biggest risk to enterprises. TCS’ innovative and responsive suite of services and solutions helps enterprises secure their cloud-led transformations and become cyber resilient,” said Santha Subramoni, Global Head, Cyber Security, TCS. “Our positioning as a Leader is a reflection of our vision and strategy, capabilities,strong focus on delivering purpose-driven solutions and the resultant market impact.”
TCS offers comprehensive,state-of-the-art, consulting-led cloud security services, which are highly digitized and tailor-made to client requirements. These offerings help customers in Asia/Pacific design a Zero-Trust based resilient architecture, modernizing their business, IT and security stack, build cloud-agnostic solutions, extend enterprise security to the cloud and design automated and vigilant operations.
TCS offers a full suite of security services around areas such as managed detection and response, identity and access management, enterprise vulnerability management, governance, risk and compliance, data privacy and protection, digital forensics and incident response, cloud security, data security and IT/OT security services.
Additionally, TCS addresses customers’ security needs, ensuring business resilience and agility with a zero trust framework as well as various solutions, tools and platforms, including a cyber vigilance platform, automated vulnerability remediation platform, consent management solution, vendor risk management solution and a digital identity as a managed service platform – TCS IdentiFence™. TCS’ Threat Management Centers located across the globe help customers with rapid and expert security services locally, while ensuring compliance with local data protection laws. Customers are partnering with TCS to secure their digital transformations and proactively defend their digital estate from cyber-attacks and vulnerabilities.
TCS Positioned as a Leader in Pharmacovigilance and Complaint Management Operations by Everest Group
A leading global IT services, consulting and business solutions organization, has been positioned as a Leader in the Everest Group PEAK Matrix® for Pharmacovigilance (PV) and Complaint Management Operations
In an assessment of 22 PV and complaint management service providers, TCS was placed highest for Vision and Capability. According to the report, TCS is one of the fastest growing service providers within the pharmacovigilance market, and has accumulated significant scale acrossthe pharmacovigilance value chain, including individual case study report (ICSR) case processing, literature screening, regulatory submission, aggregate reporting, and signal and risk management.
The report cites TCS’ strong capabilities to serve enterprises in both clinical trial drug candidates and postmarket surveillance products safety activities, as a key strength. It goes on to say that the company has made significant investments in technology to augment its services – leveraging cognitive automation for case processing and offering the TCS Advanced Drug Development (ADD) PV platform-driven services to its clientele.
“Life Sciences companies are investing in next-gen technologies to ensure patient safety and comply with evolving regulatory norms. TCS complements its pharmacovigilance services with deep medical and regulatory domain expertise and use of advanced technologies such as automation, AI and machine learning to help customers meet business and regulatory requirements effectively and efficiently,” said Vikas Jain, Business Unit Head – UK & Europe, Life Sciences, TCS. “This leadership positioning by Everest is a reflection of our strong vision, capabilities, innovation efforts and the resultant market success.”
TCS partners with leading life sciences companies and provides clinical research services such as clinical data management, regulatory affairs, PV, risk-based monitoring, biostatistics and programming, and medical writing and publishing.
Within pharmacovigilance, TCS offers end-to-end integrated safety services including ICSR case processing, signal detection, risk management, local affiliate activities, PV analytics and applications, literature surveillance, aggregate/ regulatory reporting, clinical evaluation reports, medical safety assessment, and other pharmacovigilance support activities.
TCS ADD Safety reimagines pharmacovigilance by applying machine vision, artificial intelligence, smart analytics and IoT to automate the intake, processing and analysis of safety cases. The platform significantly reduces the time taken to process safety cases and increases throughput with consistently high levels of accuracy.
In the complaint management space, TCS’ services span intake processing, complaint mailbox management, triaging, complaint coding, product investigation, complaint review, complaint approval and closure, customer communication, warranty claim processing, regulatory reporting, product return tracking, and CAPA management.
TCS has over 15 years of experience handing device complaints of various severities and numerous product 1 Pharmacovigilance and Complaint Management Operations – Services PEAK Matrix® Assessment 2021, Manu Aggarwal, Everest Group, March 19, 2021 Page 2 of 2 categories right from implants, surgical devices, surgical aiding devices, to diagnostic devices and lab equipment.
“The life sciences industry is betting big on leveraging advanced technologies across drug/device safety processes to increase operational efficiency and accuracy,” said Manu Aggarwal, Vice President, Everest Group. “TCS is one of the few service providers that not only offers end-to-end pharmacovigilance and complaint management services, deep domain expertise, and sizable operations but also differentiates itself in the market by deploying cognitive automation via its ADD Safety platform to increase efficiency and reduce manual effort for its clients.”